帕珠沙星与左氧氟沙星治疗尿路感染的成本-效果比较  

Cost-Effectiveness Analysis of Pazufloxacin Mesilate and Levofloxacin in the Treatment of Urinary Tract Infection

作　　者：魏智中[1] 

机构地区：[1]四川省宜宾市第一人民医院,四川宜宾644000

出　　处：《中国药业》2011年第23期46-47,共2页China Pharmaceuticals

摘　　要：目的分析甲磺酸帕珠沙星、左氧氟沙星治疗尿路感染成本-效果,为临床用药提供参考。方法将87例尿路感染患者随机分为2组,分别应用甲磺酸帕珠沙星、左氧氟沙星治疗,观察疗效,并进行成本-效果分析。结果 2组方案成本分别为658.00元和197.40元,总有效率为88.37%和90.91%,不良反应为11.62%和9.09%。结论左氧氟沙星组治疗方案为较安全、有效且经济的选择。Objective To analyze the cost-effectiveness of pazufloxacin mesilate and levofloxacin in the treatment of urinary tract infection to provide reference for clinical medication.Methods Eighty-seven cases of urinary tract infection were randomly divided into 2 groups and treated with pazufloxacin mesilate and levofloxacin respectively.The therapeutic effect and cost-effectiveness in the two groups were analyzed.Results The average cost was 658 Yuan for the pazufloxacin mesilate group and 197.40 Yuan for the levofloxacin group.The effective rates were 88.37%and 90.91%and the incidence rates of adverse reactions were 11.62%and 9.09%in the two groups,respectively.Conclusion Levofloxacin is safer,more effective and more economic medication for treating urinary tract infection.

关 键 词：甲磺酸帕珠沙星 盐酸左氧氟沙星 药物经济学 成本-效果 

分 类 号：F407.7[经济管理—产业经济] R969.3[医药卫生—药理学]